Chen MS, Blackstone EH, Pothier CE, Lauer MS Heart rate recovery and impact of myocardial revascularization on long-term mortality. Circulation. 2004 Nov 2;110(18):2851-7. Epub 2004 Oct 25.
Christopher Jones R, Pothier CE, Blackstone EH, Lauer MS Prognostic importance of presenting symptoms in patients undergoing exercise testing for evaluation of known or suspected coronary disease. Am J Med. 2004 Sep 15;117(6):380-9.
Frolkis JP, Pothier CE, Blackstone EH, Lauer MS Frequent ventricular ectopy after exercise as a predictor of death. N Engl J Med. 2003 Feb 27;348(9):781-90. Erratum in: N Engl J Med. 2003 Apr 10;348(15):1508.
Lauer MS, Froelicher V Abnormal heart-rate recovery after exercise. Lancet. 2002 Oct 12;360(9340):1176-7.
Lauer MS Clinical epidemiology, clinical care, and the public's health. Mayo Clin Proc. 2004 Aug;79(8):975-6. Review.
Lauer MS Exercise testing for assessment of autonomic function. Am Heart J. 2002 Oct;144(4):580-2.
O'Neill JO, Young JB, Pothier CE, Lauer MS Severe frequent ventricular ectopy after exercise as a predictor of death in patients with heart failure. J Am Coll Cardiol. 2004 Aug 18;44(4):820-6.
Vivekananthan DP, Blackstone EH, Pothier CE, Lauer MS Heart rate recovery after exercise is a predictor of mortality, independent of the angiographic severity of coronary disease. J Am Coll Cardiol. 2003 Sep 3;42(5):831-8.
Watanabe J, Thamilarasan M, Blackstone EH, Thomas JD, Lauer MS Heart rate recovery immediately after treadmill exercise and left ventricular systolic dysfunction as predictors of mortality: the case of stress echocardiography. Circulation. 2001 Oct 16;104(16):1911-6.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
